Positional cloning utilizing genomic DNA microarrays: The Niemann-Pick Type C gene as a model system

Dietrich A. Stephan, Yidong Chen, Yuan Jiang, Lindsay Malechek, Jessie Z. Gu, Christiane M. Robbins, Michael L. Bittner, Jill A. Morris, Eugene Carstea, Paul S. Meltzer, Karl Adler, Russell Garlick, Jeffrey M. Trent, Melissa A. Ashlock

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A major obstacle in positional cloning is identifying the specific mutated gene from within a large physical contig. Here we describe the application of DNA microarray technology to a defined genomic region (physical map) to identify: (i) exons without a priori sequence data and (ii) the disease gene based on differential gene expression in a recessive disorder. The feasibility was tested using resources from the positional cloning of the Neimann-Pick Type C (NP-C) disease gene, NPC1. To identify NPC1 exons and optimize the technology, an array was generated from genomic fragments of the 110-kb bacterial artificial chromosome, 108N2, which encodes NPC1. First, as a test case for blindly identifying exons, fluorescently labeled NPC1 cDNA identified 108N2 fragments that contained NPC1 exons, many of which also contained intronic sequences and could be used to determine part of the NPC1 genomic structure. Second, to demonstrate that the NPC1 disease gene could be identified based upon differential gene expression, subarrays of 108N2 fragments were hybridized with fluorescently labeled cDNA probes generated from total RNA from hamster cell lines differentially expressing NPC1. A probe derived from the NP-C cell line CT60 did not detect NPC1 exons or other genomic fragments from 108N2. In contrast, several NPC1 exons were detected by a probe generated from the non-NP-C cell line 911D5A13, which was derived from CT60, and expressed NPC1 as a consequence of stable transduction with a YAC that contains NPC1 and encompasses 108N2. Thus, the array technology identified NPC1 as a candidate gene based on a physical contig and differential NPC1 expression between NP-C and non-NP-C cells. This technique should facilitate gene identification when a physical contig exists for a region of interest and mutations result in changes in the mRNA level of the disease gene or portions thereof. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)10-18
Number of pages9
JournalMolecular Genetics and Metabolism
Volume70
Issue number1
DOIs
StatePublished - May 2000
Externally publishedYes

Fingerprint

Cloning
Microarrays
Oligonucleotide Array Sequence Analysis
Organism Cloning
Genes
Exons
DNA
Cells
Technology
Gene expression
Cell Line
Complementary DNA
Bacterial Artificial Chromosomes
Gene Expression
Chromosomes
Cricetinae
RNA
Messenger RNA
Mutation

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Positional cloning utilizing genomic DNA microarrays : The Niemann-Pick Type C gene as a model system. / Stephan, Dietrich A.; Chen, Yidong; Jiang, Yuan; Malechek, Lindsay; Gu, Jessie Z.; Robbins, Christiane M.; Bittner, Michael L.; Morris, Jill A.; Carstea, Eugene; Meltzer, Paul S.; Adler, Karl; Garlick, Russell; Trent, Jeffrey M.; Ashlock, Melissa A.

In: Molecular Genetics and Metabolism, Vol. 70, No. 1, 05.2000, p. 10-18.

Research output: Contribution to journalArticle

Stephan, DA, Chen, Y, Jiang, Y, Malechek, L, Gu, JZ, Robbins, CM, Bittner, ML, Morris, JA, Carstea, E, Meltzer, PS, Adler, K, Garlick, R, Trent, JM & Ashlock, MA 2000, 'Positional cloning utilizing genomic DNA microarrays: The Niemann-Pick Type C gene as a model system', Molecular Genetics and Metabolism, vol. 70, no. 1, pp. 10-18. https://doi.org/10.1006/mgme.2000.2989
Stephan, Dietrich A. ; Chen, Yidong ; Jiang, Yuan ; Malechek, Lindsay ; Gu, Jessie Z. ; Robbins, Christiane M. ; Bittner, Michael L. ; Morris, Jill A. ; Carstea, Eugene ; Meltzer, Paul S. ; Adler, Karl ; Garlick, Russell ; Trent, Jeffrey M. ; Ashlock, Melissa A. / Positional cloning utilizing genomic DNA microarrays : The Niemann-Pick Type C gene as a model system. In: Molecular Genetics and Metabolism. 2000 ; Vol. 70, No. 1. pp. 10-18.
@article{43197a017a0441b2ba8b63b0a7e12059,
title = "Positional cloning utilizing genomic DNA microarrays: The Niemann-Pick Type C gene as a model system",
abstract = "A major obstacle in positional cloning is identifying the specific mutated gene from within a large physical contig. Here we describe the application of DNA microarray technology to a defined genomic region (physical map) to identify: (i) exons without a priori sequence data and (ii) the disease gene based on differential gene expression in a recessive disorder. The feasibility was tested using resources from the positional cloning of the Neimann-Pick Type C (NP-C) disease gene, NPC1. To identify NPC1 exons and optimize the technology, an array was generated from genomic fragments of the 110-kb bacterial artificial chromosome, 108N2, which encodes NPC1. First, as a test case for blindly identifying exons, fluorescently labeled NPC1 cDNA identified 108N2 fragments that contained NPC1 exons, many of which also contained intronic sequences and could be used to determine part of the NPC1 genomic structure. Second, to demonstrate that the NPC1 disease gene could be identified based upon differential gene expression, subarrays of 108N2 fragments were hybridized with fluorescently labeled cDNA probes generated from total RNA from hamster cell lines differentially expressing NPC1. A probe derived from the NP-C cell line CT60 did not detect NPC1 exons or other genomic fragments from 108N2. In contrast, several NPC1 exons were detected by a probe generated from the non-NP-C cell line 911D5A13, which was derived from CT60, and expressed NPC1 as a consequence of stable transduction with a YAC that contains NPC1 and encompasses 108N2. Thus, the array technology identified NPC1 as a candidate gene based on a physical contig and differential NPC1 expression between NP-C and non-NP-C cells. This technique should facilitate gene identification when a physical contig exists for a region of interest and mutations result in changes in the mRNA level of the disease gene or portions thereof. (C) 2000 Academic Press.",
author = "Stephan, {Dietrich A.} and Yidong Chen and Yuan Jiang and Lindsay Malechek and Gu, {Jessie Z.} and Robbins, {Christiane M.} and Bittner, {Michael L.} and Morris, {Jill A.} and Eugene Carstea and Meltzer, {Paul S.} and Karl Adler and Russell Garlick and Trent, {Jeffrey M.} and Ashlock, {Melissa A.}",
year = "2000",
month = "5",
doi = "10.1006/mgme.2000.2989",
language = "English (US)",
volume = "70",
pages = "10--18",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Positional cloning utilizing genomic DNA microarrays

T2 - The Niemann-Pick Type C gene as a model system

AU - Stephan, Dietrich A.

AU - Chen, Yidong

AU - Jiang, Yuan

AU - Malechek, Lindsay

AU - Gu, Jessie Z.

AU - Robbins, Christiane M.

AU - Bittner, Michael L.

AU - Morris, Jill A.

AU - Carstea, Eugene

AU - Meltzer, Paul S.

AU - Adler, Karl

AU - Garlick, Russell

AU - Trent, Jeffrey M.

AU - Ashlock, Melissa A.

PY - 2000/5

Y1 - 2000/5

N2 - A major obstacle in positional cloning is identifying the specific mutated gene from within a large physical contig. Here we describe the application of DNA microarray technology to a defined genomic region (physical map) to identify: (i) exons without a priori sequence data and (ii) the disease gene based on differential gene expression in a recessive disorder. The feasibility was tested using resources from the positional cloning of the Neimann-Pick Type C (NP-C) disease gene, NPC1. To identify NPC1 exons and optimize the technology, an array was generated from genomic fragments of the 110-kb bacterial artificial chromosome, 108N2, which encodes NPC1. First, as a test case for blindly identifying exons, fluorescently labeled NPC1 cDNA identified 108N2 fragments that contained NPC1 exons, many of which also contained intronic sequences and could be used to determine part of the NPC1 genomic structure. Second, to demonstrate that the NPC1 disease gene could be identified based upon differential gene expression, subarrays of 108N2 fragments were hybridized with fluorescently labeled cDNA probes generated from total RNA from hamster cell lines differentially expressing NPC1. A probe derived from the NP-C cell line CT60 did not detect NPC1 exons or other genomic fragments from 108N2. In contrast, several NPC1 exons were detected by a probe generated from the non-NP-C cell line 911D5A13, which was derived from CT60, and expressed NPC1 as a consequence of stable transduction with a YAC that contains NPC1 and encompasses 108N2. Thus, the array technology identified NPC1 as a candidate gene based on a physical contig and differential NPC1 expression between NP-C and non-NP-C cells. This technique should facilitate gene identification when a physical contig exists for a region of interest and mutations result in changes in the mRNA level of the disease gene or portions thereof. (C) 2000 Academic Press.

AB - A major obstacle in positional cloning is identifying the specific mutated gene from within a large physical contig. Here we describe the application of DNA microarray technology to a defined genomic region (physical map) to identify: (i) exons without a priori sequence data and (ii) the disease gene based on differential gene expression in a recessive disorder. The feasibility was tested using resources from the positional cloning of the Neimann-Pick Type C (NP-C) disease gene, NPC1. To identify NPC1 exons and optimize the technology, an array was generated from genomic fragments of the 110-kb bacterial artificial chromosome, 108N2, which encodes NPC1. First, as a test case for blindly identifying exons, fluorescently labeled NPC1 cDNA identified 108N2 fragments that contained NPC1 exons, many of which also contained intronic sequences and could be used to determine part of the NPC1 genomic structure. Second, to demonstrate that the NPC1 disease gene could be identified based upon differential gene expression, subarrays of 108N2 fragments were hybridized with fluorescently labeled cDNA probes generated from total RNA from hamster cell lines differentially expressing NPC1. A probe derived from the NP-C cell line CT60 did not detect NPC1 exons or other genomic fragments from 108N2. In contrast, several NPC1 exons were detected by a probe generated from the non-NP-C cell line 911D5A13, which was derived from CT60, and expressed NPC1 as a consequence of stable transduction with a YAC that contains NPC1 and encompasses 108N2. Thus, the array technology identified NPC1 as a candidate gene based on a physical contig and differential NPC1 expression between NP-C and non-NP-C cells. This technique should facilitate gene identification when a physical contig exists for a region of interest and mutations result in changes in the mRNA level of the disease gene or portions thereof. (C) 2000 Academic Press.

UR - http://www.scopus.com/inward/record.url?scp=0034043009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034043009&partnerID=8YFLogxK

U2 - 10.1006/mgme.2000.2989

DO - 10.1006/mgme.2000.2989

M3 - Article

C2 - 10833327

AN - SCOPUS:0034043009

VL - 70

SP - 10

EP - 18

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1

ER -